youtube_live
Q2 2027 earnings • released • EPS beat +2.80% • Revenue beat +2.49%
See resultschevron_right
DOCS:NYSE
Doximity Inc
$32.51
arrow_downward
-2.02%(-0.67) 1D
$32.51
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:03 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DOCS...
Open
$30.26
High
$32.62
Low
$29.80
Mkt. cap
5.79B
Avg. vol.
2.92M
Volume
4.29M
P/E ratio
38.55
52-wk high
$58.24
52-wk low
$17.15
EPS
$0.84
Beta
1.29
Shares outstanding
127.35M
No. of employees
880
Open
$30.26
High
$32.62
Low
$29.80
Mkt. cap
5.79B
Avg. vol.
2.92M
Volume
4.29M
P/E ratio
38.55
52-wk high
$58.24
52-wk low
$17.15
EPS
$0.84
Beta
1.29
Shares outstanding
127.35M
No. of employees
880
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Doximity Q2 Earnings Call Highlights
Investing.com
·
2 days ago
Why is Doximity stock sliding today?
The Globe and Mail
·
2 days ago
Doximity (DOCS) Q2 2027 Earnings Call Transcript
TradingView
·
2 days ago
Doximity drops despite FQ2 beats, revenue guidance raise
Profile
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration. Wikipedia
About Doximity Inc
CEOJeff Tangney
Employees880
FoundedJun 2010
HeadquartersSan Francisco, California, United States
SectorHealth Care
Industry-
Websitedoximity.com
Analyst ratings
Based on 13 analysts giving stock ratings to DOCS in the past 3 months
Hold
Buy
4
Hold
7
Sell
2
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for DOCS in the last 3 months.
Highest
Current $32.51
$40.00 (+23.04%)
Average
$29.33 (-9.78%)
Lowest
$18.00 (-44.63%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Ryan Daniels William Blair | Buy | Maintained | - | - | 11/05/2026 |
Brian Tanquilut Jefferies | Hold | Maintained | $30.00 | -7.7% | 11/06/2026 |
Jailendra Singh Truist Financial | Hold | Reiterated | $24.00 | -26.2% | 11/06/2026 |
Richard Close Canaccord Genuity | Buy | Reiterated | $40.00 | +23% | 11/06/2026 |
Ryan Halsted RBC Capital | Buy | Reiterated | $34.00 | +4.6% | 11/06/2026 |
Craig Hettenbach Morgan Stanley | Buy | Maintained | $35.00 | +7.7% | 11/06/2026 |
Allen Lutz Bank of America Securities | Sell | Maintained | $23.00 | -29.3% | 11/06/2026 |
Glen Santangelo Barclays | Hold | Maintained | $27.00 | -16.9% | 11/06/2026 |
Stan Berenshteyn Wells Fargo | Sell | Reiterated | $18.00 | -44.6% | 11/06/2026 |
Elizabeth Anderson CFA Evercore ISI | Hold | Maintained | $35.00 | +7.7% | 09/29/2026 |
Eugene Mannheimer Freedom Capital Markets | Hold | Downgraded | $27.00 | -16.9% | 09/08/2026 |
Steven Valiquette Mizuho Securities | Hold | Maintained | $28.00 | -13.9% | 08/11/2026 |
Alexei Gogolev J.P. Morgan | Hold | Maintained | $31.00 | -4.6% | 08/10/2026 |
Brian Peterson Raymond James | Buy | Maintained | $38.00 | +16.9% | 08/07/2026 |
Jessica Tassan Piper Sandler | Buy | Reiterated | $47.00 | +44.6% | 08/07/2026 |
Sean Dodge BMO Capital | Hold | Reiterated | $30.00 | -7.7% | 08/06/2026 |
Scott Berg Needham | Buy | Maintained | $41.00 | +26.1% | 08/07/2026 |
Ryan MacDonald Needham | Buy | Maintained | $41.00 | +26.1% | 08/07/2026 |
Anne Samuel J.P. Morgan | Hold | Maintained | $28.00 | -13.9% | 05/14/2026 |
David Roman Goldman Sachs | Hold | Reiterated | $24.00 | -26.2% | 05/15/2026 |
Michael Cherny Leerink Partners | Buy | Reiterated | $25.00 | -23.1% | 05/15/2026 |
David Larsen BTIG | Hold | Downgraded | - | - | 05/14/2026 |
Vikram Kesavabhotla Robert W. Baird | Hold | Downgraded | $18.00 | -44.6% | 05/14/2026 |
Scott Schoenhaus KeyBanc | Hold | Maintained | - | - | 05/14/2026 |
Last report
Nov 6, 2026
Fiscal period
Q2 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.36 / $0.35
+2.80%beat
arrow_upward
Revenue / Est. (USD)
174.54M / 170.30M
+2.49%beat
arrow_upward
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 168.52M | 185.05M | 145.37M | 156.62M |
Cost of goods sold | 16.42M | 18.70M | 19.41M | 23.69M |
Cost of revenue | 16.42M | 18.70M | 19.41M | 23.69M |
Research and development expenses | 30.20M | 34.60M | 39.11M | 38.48M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 56.94M | 59.78M | 55.48M | 60.72M |
Operating expense | 87.14M | 94.38M | 94.59M | 99.19M |
Total operating expenses | 103.56M | 113.08M | 114.00M | 122.88M |
Operating income | 64.96M | 71.98M | 31.37M | 33.73M |
Other non operating income | -178.00K | -158.00K | -235.00K | -286.00K |
EBT including unusual items | 72.94M | 80.80M | 32.12M | 40.36M |
EBT excluding unusual items | 74.22M | 80.76M | 38.60M | 40.39M |
Income tax expense | 10.88M | 19.24M | 13.01M | 16.05M |
Effective tax rate | 14.92% | 23.81% | 40.49% | 39.76% |
Other operating expenses | - | - | - | - |
Net income | 62.06M | 61.56M | 19.11M | 24.32M |
Net profit margin | 36.82% | 33.27% | 13.15% | 15.53% |
Earnings per share | 0.45 | 0.46 | 0.26 | 0.29 |
Interest and investment income | 9.44M | 8.94M | 7.46M | 6.94M |
Interest expense | - | - | - | - |
Net interest expenses | 9.44M | 8.94M | 7.46M | 6.94M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 66.73M | 74.06M | 33.40M | 35.82M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events